Acneiform reaction to erlotinib. (Record no. 17537934)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01251 a2200337 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250515094408.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 200802s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1710-3568 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.2310/6620.2007.06037 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Schalock, Peter C |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20080201 |
245 00 - TITLE STATEMENT | |
Title | Acneiform reaction to erlotinib. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Dermatitis : contact, atopic, occupational, drug |
Date of publication, distribution, etc. | Dec 2007 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 230-1 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Case Reports; Journal Article |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Acneiform Eruptions |
General subdivision | etiology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Agents |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Carcinoma, Non-Small-Cell Lung |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Eruptions |
General subdivision | etiology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Erlotinib Hydrochloride |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Lung Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Protein Kinase Inhibitors |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Quinazolines |
General subdivision | administration & dosage |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Zug, Kathryn A |
773 0# - HOST ITEM ENTRY | |
Title | Dermatitis : contact, atopic, occupational, drug |
Related parts | vol. 18 |
-- | no. 4 |
-- | p. 230-1 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.2310/6620.2007.06037">https://doi.org/10.2310/6620.2007.06037</a> |
Public note | Available from publisher's website |
No items available.